Two studies presented at AHA show the capacity of AI to improve sonographer accuracy, consistency, and workflow.

Although some of the trial’s methodology was critiqued, the results provide fodder for shared decision-making discussions.

One is an siRNA biologic, the other an oral agent, but both lowered Lp(a) levels by 80% or more in ASCVD patients.